Yutaka Yamamoto

Summary

Country: Japan

Publications

  1. pmc Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
    Yutaka Yamamoto
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
    Onco Targets Ther 4:123-36. 2011
  2. doi request reprint Clinical significance of basal-like subtype in triple-negative breast cancer
    Yutaka Yamamoto
    Department of Breast and Endocrine Surgery, Kumamoto University Graduate School of Medical Sciences, 1 1 1 Honjo, Kumamoto, Kumamoto 860 8556, Japan
    Breast Cancer 16:260-7. 2009
  3. doi request reprint Clinicopathological features and treatment strategy for triple-negative breast cancer
    Yutaka Yamamoto
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo, Kumamoto 860 8556, Japan
    Int J Clin Oncol 15:341-51. 2010
  4. ncbi request reprint Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer
    Yutaka Yamamoto
    Department of Breast and Endocrine Surgery, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University Graduate School of Medical Sciences, 1 1 1 Honjo, Kumamoto 860 8556 Kumamoto, Japan
    Breast Cancer Res Treat 110:465-75. 2008
  5. doi request reprint Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer
    Yutaka Yamamoto
    Department of Breast and Endocrine Surgery, Kumamoto University School of Medicine, 1 1 1 Honjo, Kumamoto 860 8556, Japan
    Int J Clin Oncol 13:384-94. 2008
  6. doi request reprint Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens
    Satoko Yamamoto
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo Kumamoto, Kumamoto, Japan
    Breast Cancer 20:262-70. 2013
  7. doi request reprint Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens
    Mutsuko Ibusuki
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo, Kumamoto, Kumamoto, 860 8556, Japan
    Breast Cancer 20:159-66. 2013
  8. pmc Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
    Yasuhiro Okumura
    Department of Breast and Endocrine Surgery, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Honjo 1 1 1, Kumamoto 860 8556, Japan
    BMC Cancer 8:287. 2008
  9. ncbi request reprint Nuclear corepressor 1 expression predicts response to first-line endocrine therapy for breast cancer patients on relapse
    Zhen huan Zhang
    Department of Breast and Endocrine Surgery, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
    Chin Med J (Engl) 122:1764-8. 2009
  10. ncbi request reprint Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer
    Mitsuhiro Hayashi
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
    Ann Surg Oncol 19:3042-9. 2012

Collaborators

Detail Information

Publications39

  1. pmc Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
    Yutaka Yamamoto
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
    Onco Targets Ther 4:123-36. 2011
    ..This review summarizes the most relevant knowledge on nab-paclitaxel for treating breast cancer in terms of clinical usefulness including efficacy and safety of this new agent...
  2. doi request reprint Clinical significance of basal-like subtype in triple-negative breast cancer
    Yutaka Yamamoto
    Department of Breast and Endocrine Surgery, Kumamoto University Graduate School of Medical Sciences, 1 1 1 Honjo, Kumamoto, Kumamoto 860 8556, Japan
    Breast Cancer 16:260-7. 2009
    ..Triple-negative cancer consists of two subtypes: basal-like and non-basal-like. The aim of this study is to clarify the clinical and biological characteristics of these two subtypes of TN cancer...
  3. doi request reprint Clinicopathological features and treatment strategy for triple-negative breast cancer
    Yutaka Yamamoto
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo, Kumamoto 860 8556, Japan
    Int J Clin Oncol 15:341-51. 2010
    ..Concerning therapeutic strategies for TNBC, it is most important to develop novel effective approaches for TNBC treatment and high-throughput predictive tools for standard chemotherapy and novel agents...
  4. ncbi request reprint Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer
    Yutaka Yamamoto
    Department of Breast and Endocrine Surgery, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University Graduate School of Medical Sciences, 1 1 1 Honjo, Kumamoto 860 8556 Kumamoto, Japan
    Breast Cancer Res Treat 110:465-75. 2008
    ..The aim of this study is to clarify characteristics of invasive breast cancer with expression of Hypoxia-induced factor 1alpha (HIF-1alpha) which is induced by hypoxia and signal transduction of growth factors...
  5. doi request reprint Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer
    Yutaka Yamamoto
    Department of Breast and Endocrine Surgery, Kumamoto University School of Medicine, 1 1 1 Honjo, Kumamoto 860 8556, Japan
    Int J Clin Oncol 13:384-94. 2008
    ....
  6. doi request reprint Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens
    Satoko Yamamoto
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo Kumamoto, Kumamoto, Japan
    Breast Cancer 20:262-70. 2013
    ....
  7. doi request reprint Establishment of a standardized gene-expression analysis system using formalin-fixed, paraffin-embedded, breast cancer specimens
    Mutsuko Ibusuki
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo, Kumamoto, Kumamoto, 860 8556, Japan
    Breast Cancer 20:159-66. 2013
    ..In this study our objective was to independently establish a standardized gene-expression assay system using routinely processed, formalin-fixed, paraffin-embedded (FFPE) tissues...
  8. pmc Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
    Yasuhiro Okumura
    Department of Breast and Endocrine Surgery, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Honjo 1 1 1, Kumamoto 860 8556, Japan
    BMC Cancer 8:287. 2008
    ..Identification of biological differences between DCIS and DCIS-Mi may aid in understanding of the nature and causes of the progression of DCIS to invasiveness...
  9. ncbi request reprint Nuclear corepressor 1 expression predicts response to first-line endocrine therapy for breast cancer patients on relapse
    Zhen huan Zhang
    Department of Breast and Endocrine Surgery, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
    Chin Med J (Engl) 122:1764-8. 2009
    ..Nuclear corepressor 1 (NCOR1) is one of the ER a transcription repressor. The objective of the study is to investigate the expression of NCOR1 at the protein level and pursue its predictive value for breast cancer endocrine therapy...
  10. ncbi request reprint Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer
    Mitsuhiro Hayashi
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
    Ann Surg Oncol 19:3042-9. 2012
    ..However, the value of EG for prediction of response to systemic therapy is poorly understood...
  11. doi request reprint Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor
    Yutaka Yamamoto
    Department of Breast and Endocrine Surgery, Kumamoto University, Japan
    Breast Cancer 17:254-60. 2010
    ..In this study, we investigated the efficacy and safety of toremifene (TOR, Fareston(®)), a selective estrogen receptor modulator (SERM)...
  12. doi request reprint Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer
    Peifen Fu
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo, Kumamoto, Kumamoto, 860 8556, Japan
    Breast Cancer 19:321-8. 2012
    ....
  13. pmc A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer
    Satoko Yamamoto
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo Kumamoto, Kumamoto 860 8556, Japan
    BMC Cancer 13:217. 2013
    ....
  14. doi request reprint Estrogen receptor alpha gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients
    Saori Tomita
    Department of Breast and Endocrine Surgery, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
    Cancer Sci 100:1012-7. 2009
    ..Our data suggest that ESR1 amplification might prove to be helpful in selecting patients who may potentially benefit from endocrine therapy...
  15. doi request reprint Pathological lymph node involvement at surgery is a significant predictive factor of recurrence in locally advanced breast cancer treated with concomitant epirubicin-docetaxel neoadjuvant chemotherapy: a cohort study
    Kazuharu Kai
    Breast and Endocrine Surgery, Faculty of Medical and Pharmaceutical Science, Kumamoto University, 1 1 1 Honjo, Kumamoto, 860 8556, Japan
    Breast Cancer 16:42-8. 2009
    ..Therefore, in the present study, we adopted the more clinically relevant categorization of evaluating postoperative axillary lymph node status and retrospectively studied its significance in predicting patients' survival...
  16. ncbi request reprint The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+ HER2- breast cancer
    Saori Fujiwara
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo, Chuo Ku, Kumamoto 860 8556, Japan
    Oncotarget 5:3919-30. 2014
    ..In conclusion, analysis of splicing variants and 4ICD localization should be considered when targeting HER4 as a novel ER+/HER2- breast cancer treatment. ..
  17. doi request reprint Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 and the corresponding gene expression score in breast cancer
    Mutsuko Yamamoto-Ibusuki
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
    Mod Pathol 26:79-86. 2013
    ....
  18. doi request reprint Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients
    Mutsuko Ibusuki
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
    Cancer Sci 102:439-45. 2011
    ..In breast cancer, reduced FBXW7 mRNA expression may have independent prognostic potential through the enhanced function of cell cycle regulatory proteins...
  19. ncbi request reprint Potential advantage of preoperative three-dimensional mapping of sentinel nodes in breast cancer by a hybrid single photon emission CT (SPECT)/CT system
    Mutsuko Ibusuki
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo Kumamoto, Kumamoto 860 8556, Japan
    Surg Oncol 19:88-94. 2010
    ..This study aims to assess the role of three-dimensional single-photon emission computed tomography (3D-SPECT/CT) in sentinel node (SN) identification, and to analyze the impact of such information on estimating metastases to SNs...
  20. ncbi request reprint Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer
    Zhenhuan Zhang
    Department of Breast and Endocrine Surgery, Nagoya City University Hospital, Nagoya, Japan
    Clin Cancer Res 12:6410-4. 2006
    ..However, its clinical importance for breast cancer patients remains undetermined. This prompted us to investigate its expression level in breast cancer patients to clarify its clinical significance...
  21. ncbi request reprint High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level
    Chunsen Xu
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo Kumamoto, Kumamoto, 860 8556, Japan
    Breast Cancer 21:482-90. 2014
    ..The purpose of this study was to examine the expression of survivin and its role in predicting clinical outcome in a series of human breast cancer cases both at the mRNA and protein level...
  22. ncbi request reprint Clinical significance of pretherapeutic Ki67 as a predictive parameter for response to neoadjuvant chemotherapy in breast cancer; is it equally useful across tumor subtypes?
    Aiko Sueta
    Department of Breast and Endocrine Surgery, Kumamoto University Hospital, Chuo Ku, Kumamoto, Japan
    Surgery 155:927-35. 2014
    ..It is unclear whether expression of Ki67 is particularly helpful for prediction of pCR across tumor subtypes...
  23. pmc Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: results of the JMTO BC08-01 phase II trial
    Reiki Nishimura
    Department of Breast and Endocrine Surgery, Kumamoto City Hospital, Kumamoto 862 8505, Japan
    Oncol Rep 29:1707-13. 2013
    ..The treatment may become viable treatment in the future, particularly when TAM is ineffective or contraindicated. Further studies and discussion are warranted...
  24. doi request reprint Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival
    Andri Rezano
    Department of Immunology, Graduate School of Medical Sciences, Kumamoto University, 1 1 1, Honjo, Chuo Ku, Kumamoto 860 8556, Japan
    BMC Cancer 13:562. 2013
    ..Because DSS1, a mammalian component of the transcription/RNA export complex, is known to stabilize BRCA2, we investigated how the expression of DSS1 is associated with clinical parameters in breast cancers...
  25. ncbi request reprint [A case of estrogen receptor-positive metastatic breast cancer in a postmenopausal woman treated with ethinyl estradiol]
    Hitomi Goto
    Dept of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University
    Gan To Kagaku Ryoho 40:2569-71. 2013
    ..This therapy can be considered to be effective in patients with ER-positive metastatic breast cancer who have been heavily treated with endocrine therapies and chemotherapies...
  26. ncbi request reprint [Experience of high-dose toremifene treatment for postmenopausal women with metastatic breast cancer]
    Yutaka Yamamoto
    Dept of Breast and Endocrine Surgery, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University
    Gan To Kagaku Ryoho 32:1415-9. 2005
    ..Adverse events induced by high-dose TOR treatment were tolerable. High-dose TOR may be one of the optional treatments for patients with MBC after TAM and AI treatment...
  27. doi request reprint Midkine in plasma as a novel breast cancer marker
    Mutsuko Ibusuki
    Department of Breast and Endocrine Surgery, Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Kumamoto, Japan
    Cancer Sci 100:1735-9. 2009
    ..Midkine may be a useful novel tumor marker for detection of breast cancer, superior to conventional tumor markers...
  28. ncbi request reprint [Prediction for efficacy of endocrine therapy for breast cancers using gene profiling]
    Hirotaka Iwase
    Department of Breast and Endocrine Surgery, Kumamoto University
    Nihon Rinsho 65:549-54. 2007
  29. pmc PTIP associated protein 1, PA1, is an independent prognostic factor for lymphnode negative breast cancer
    Takashi Takeshita
    Department of Breast and Endocrine Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan
    PLoS ONE 8:e80552. 2013
    ..025), which was verified by univariate and multivariate analyses. These investigations suggested PA1 expression could be a potential prognostic indicator for RFS in breast cancer. ..
  30. doi request reprint Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression
    Peifen Fu
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, 860 8556, Japan
    Breast Cancer Res Treat 130:307-17. 2011
    ..In particular, IGF1R mRNA expression appeared to be a good prognostic marker both in the entire cohort and in the luminal subtype group. These data may serve as background information for IGF1R-targeted therapy...
  31. doi request reprint Advantage of sentinel lymph node biopsy before neoadjuvant chemotherapy in breast cancer treatment
    Hirotaka Iwase
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
    Surg Today 39:374-80. 2009
    ..To identify the initial cancer stage in patients who will be treated by systemic therapy before surgery, SLNB should be performed prior to systemic treatments, using a well-developed navigating tool, such as SPECT/CT...
  32. pmc Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer
    Kazuharu Kai
    Department of Breast and Endocrine Surgery, Faculty of Medical and Pharmaceutical Science, Kumamoto University, Kumamoto, Japan
    BMC Cancer 8:262. 2008
    ..In addition, few studies have analyzed LOH status at the ATBF1-A locus, located in the 16q22 minimal region...
  33. ncbi request reprint A case report of paraneoplastic neurological syndrome associated with occult breast cancer
    Teru Kawasoe
    Department of Breast and Endocrine Surgery, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Japan
    Breast Cancer 13:202-4. 2006
    ..Her mammogram demonstrated pleomorphic calcifications. Although local and systemic therapies were given, no significant improvement in the neurologic condition was found...
  34. ncbi request reprint Association of ErbB1-4 expression in invasive breast cancer with clinicopathological characteristics and prognosis
    Saori Fujiwara
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, 1 1 1 Honjo, Chuo Ku, Kumamoto, 860 8556, Japan
    Breast Cancer 21:472-81. 2014
    ..However, the prognostic relevance to breast cancer patients of the other ErbB family members has long been a matter of debate...
  35. ncbi request reprint Clinical significance of CYLD downregulation in breast cancer
    Mitsuhiro Hayashi
    Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan
    Breast Cancer Res Treat 143:447-57. 2014
    ..Moreover, reduced CYLD expression was an independent factor for poor prognosis in breast cancer. CYLD downregulation may promote breast cancer metastasis via NF-κB activation, including RANKL signaling...
  36. doi request reprint Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis
    Motoyoshi Endo
    Department of Molecular Genetics, Kumamoto University, Kumamoto, Japan
    Cancer Res 72:1784-94. 2012
    ..Overall, our findings showed that tumor cell-derived ANGPTL2 drives metastasis and provided an initial proof of concept for blockade of its action as a strategy to antagonize the metastatic process...
  37. doi request reprint Stromal sarcoma of the breast with lung metastases showing a clinical complete response to doxorubicin plus ifosfamide treatment: report of a case
    Aiko Sueta
    Department of General Surgery, Kumamoto Rousai Hospital, Kumamoto, Japan
    Surg Today 41:1145-9. 2011
    ..This case demonstrates the effectiveness of chemotherapy with doxorubicin plus ifosfamide for lung metastases from breast stromal sarcoma...
  38. ncbi request reprint Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues
    Yutaka Yamamoto
    Department of Surgery II, Hospital, Kumamoto University Medical School, 1 1 1 Honjo, Kumamoto 860 8556, Japan
    Oncol Rep 10:791-6. 2003
    ..It may be useful to study the expression of aromatase and E1-STS using immunocytochemical analysis for understanding the tumor characteristics in breast cancer...